| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.008 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |